Honasa Consumer Limited has announced robust financial results for the quarter and year ended March 31, 2026. The company delivered 20% YoY revenue growth for the fiscal year, reaching INR 2,479 Cr, while tripling its EBITDA. Reflecting its commitment to rewarding shareholders, the Board has recommended a maiden dividend of INR 3 per equity share, amounting to a total payout of approximately INR 98 Cr, subject to shareholder approval.
Fiscal Year 2026 Financial Milestones
For the full financial year 2026, Honasa achieved INR 2,479 Cr in revenue from operations, representing a 20% year-on-year growth. The company demonstrated significant operational efficiency, tripling its EBITDA to INR 231 Cr, with an EBITDA margin of 9.3%. Profit After Tax (PAT) for the year stood at INR 200 Cr, marking a 175%+ increase compared to the previous year.
Q4 FY26 Performance Highlights
The final quarter of the fiscal year saw strong momentum, with the company recording its highest-ever quarterly revenue of INR 682 Cr, a 28% year-on-year growth. The company maintained a negative working capital cycle of (14) days and achieved a gross profit margin of 71.4%, reflecting a 69 bps YoY improvement. EBITDA for the quarter reached INR 77 Cr, growing over 185% year-on-year.
Strategic Growth and Market Positioning
Honasa’s focus categories grew at 35%+, contributing to over 80% of the company’s total revenue in Q4 FY26. The company successfully scaled its ‘Hero’ products, such as Mamaearth Rice Face Wash and The Derma Co. Hyaluronic Sunscreen. Furthermore, the company successfully consolidated its latest acquisition, Reginald Men, which achieved an ARR of over INR 100 Cr in its first quarter of integration.
Commitment to Shareholders
In a significant milestone, the Board of Directors has recommended the company’s first-ever dividend. Shareholders are set to receive INR 3 per equity share, representing 30% of the face value. This distribution accounts for 51.2% of the FY26 Standalone PAT and represents a total cash payout of approximately INR 98 Cr, subject to approval at the upcoming Annual General Meeting.
Future Outlook: Nutraceuticals and Innovation
Looking ahead, Honasa is expanding its presence in the ‘Inside Out’ beauty segment, specifically targeting the INR 16K Cr+ vitamins, minerals, and supplements market in India. The company reports a ~40% growth in consumer searches for hair and skin care nutraceuticals, positioning itself to capture this shift from topical solutions to integrated inside-out beauty routines.
Source: BSE
